{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:04:22Z","timestamp":1791097462768,"version":"4.1.0"},"reference-count":144,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1128\/aac.42.5.995","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:31:56Z","timestamp":1539045116000},"page":"995-1004","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":90,"title":["Prevention of Infection Due to<i>Pneumocystis carinii<\/i>"],"prefix":"10.1128","volume":"42","author":[{"given":"Jay Alan","family":"Fishman","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Infectious Disease and Transplantation Units, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"1343","article-title":"Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and Toxoplasma encephalitis.","volume":"9","author":"Antinori A.","year":"1995","unstructured":"Antinori A. Murri R. Ammassari A. De Luca A. Linzalone A. Cingolani A. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and Toxoplasma encephalitis. J. Acquired Immune Defic. Syndr. 9 1995 1343 1350","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/clinids\/22.6.920","article-title":"Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.","volume":"22","author":"Arend S. M.","year":"1996","unstructured":"Arend S. M. Westendorp R. G. Kroon F. P. van\u2019t Wout J. W. Vandenbroucke J. P. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin. Infect Dis. 22 1996 920 925","journal-title":"Clin. Infect Dis."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00079a027","article-title":"Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide.","volume":"35","author":"Balkovec J. M.","year":"1992","unstructured":"Balkovec J. M. Black R. M. Hammond M. L. Heck J. V. Zambias R. A. Abruzzo G. Bartizal K. Kropp H. Trainor C. Schwartz R. E. Schmatz D. M. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. J. Med. Chem. 35 1992 194 198","journal-title":"J. Med. Chem."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clinids\/23.4.718","article-title":"Clindamycin\/primaquine as prophylaxis for Pneumocystis carinii pneumonia.","volume":"23","author":"Barber B. A.","year":"1996","unstructured":"Barber B. A. Pegram P. S. High K. P. Clindamycin\/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23 1996 718 722","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1432-2277.1993.tb00755.x","article-title":"Infections in human liver recipients: different patterns early and late after transplantation.","volume":"6","author":"Barkholt L.","year":"1993","unstructured":"Barkholt L. Ericzon B. G. Tollemar J. Malmborg A. S. Ehrnst A. Wilczek H. Infections in human liver recipients: different patterns early and late after transplantation. Transplant. Int. 6 1993 77 84","journal-title":"Transplant. Int."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.1.5.511-516.1994"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1859"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2436"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(90)90089-U"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.6.1100-1102.1988"},{"key":"e_1_3_1_12_2","unstructured":"Baxter J. D. Thompson M. A. MacArthur R. D. Markowitz N. P. Mayers D. L. LiVolsi M. A. Makohon Dehlinger L. H. Howard S. F. Neaton J. D. The 036 Protocol Team for the Terry Beirn Community Programs for Clinical Research on AIDS Viral load and risk of specific opportunistic infections in patients with CD4 counts \u2264200 cells\/mm 2 enrolled in CPCRA 036 abstr. 329. Abstracts of the 35th Annual Meeting of the Infectious Disease Society of America 1997 1997"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/5.2.186"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9343(96)00008-3","article-title":"Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in HIV-infected patients with allergies to trimethoprim-sulfamethoxazole.","volume":"100","author":"Beumont M. G.","year":"1996","unstructured":"Beumont M. G. Graziani A. Ubel P. A. MacGregor R. R. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in HIV-infected patients with allergies to trimethoprim-sulfamethoxazole. Am. J. Med. 100 1996 611 616","journal-title":"Am. J. Med."},{"key":"e_1_3_1_15_2","unstructured":"Borleffs J. C. C. Pentamidine versus two doses of cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients abstr. O-8A. International Congress on Drug Therapy of HIV Infection 1992"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection.","volume":"332","author":"Bozzette S. A.","year":"1995","unstructured":"Bozzette S. A. Finkelstein D. M. Spector S. A. Frame P. Powderly W. G. He W. Phillips L. Craven D. Van der Horst C. Feinberg J. NIAID AIDS Clinical Trials Group A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332 1995 693 699","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/thx.44.7.591","article-title":"Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis.","volume":"44","author":"Bradburne P. M.","year":"1989","unstructured":"Bradburne P. M. Bettensohn D. B. Opal S. M. McCool F. D. Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis. Thorax 44 1989 591 593","journal-title":"Thorax"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.7.1194"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1001\/archinte.1994.00420220085010","article-title":"Microbiology of community acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection.","volume":"154","author":"Burack J. H.","year":"1994","unstructured":"Burack J. H. Hahn J. A. Saint-Maurice D. Jacobson M. A. Microbiology of community acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Arch. Intern. Med. 154 1994 2589 2596","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_1_20_2","unstructured":"Carl J. L. Evaluation of the cost effectiveness of trimethoprim\/sulfamethoazole (TMP\/SMX) desensitization in HIV-infected patients with intolerance to TMP\/SMX abstr. I221b Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995 245 American Society for Microbiology Washington D.C"},{"key":"e_1_3_1_21_2","first-page":"1","article-title":"1997 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention 1997 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Morbid. Mortal. Weekly Rep. 46 1997 1 46","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00002030-199108000-00002","article-title":"Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients.","volume":"5","author":"Chave J.","year":"1991","unstructured":"Chave J. David S. Wauters J. Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS 5 1991 927 932","journal-title":"AIDS"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/j.1552-4604.1995.tb04042.x","article-title":"Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.","volume":"35","author":"Conte J. E.","year":"1995","unstructured":"Conte J. E. Jr. Golden J. A. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 35 1995 1166 1173","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.1077"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.6.796"},{"key":"e_1_3_1_26_2","unstructured":"Duval X. Clayette P. Bosquet N. Frettier P. Martin M. Salmon-Ceron D. Vilde J. Dormont D. Effect of dapsone (DDS) on HIV-1 replication in primary cell culture abstr. A10 Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1996 188 American Society for Microbiology Washington D.C"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/334519a0","article-title":"Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi.","volume":"334","author":"Edman J. C.","year":"1988","unstructured":"Edman J. C. Kovacs J. A. Masur H. Santi D. V. Elwood J. H. Sogin M. L. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334 1988 519 522","journal-title":"Nature"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.17.6503"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/351155a0"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0268-960X(94)90079-W","article-title":"Prophylaxis against late infection following splenectomy and bone marrow transplantation.","volume":"8","author":"Fielding A. K.","year":"1994","unstructured":"Fielding A. K. Prophylaxis against late infection following splenectomy and bone marrow transplantation. Blood Rev. 8 1994 179 191","journal-title":"Blood Rev."},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-105-4-629_1","article-title":"Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.","volume":"105","author":"Fischl M. A.","year":"1986","unstructured":"Fischl M. A. Dickinson G. M. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105 1986 629","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.8.1185"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30713-3"},{"key":"e_1_3_1_34_2","unstructured":"Fishman J. A. A gene family related to the major antigen gene of Pneumocystis. In Bristol-Myers Squibb Symposium on Cell and Molecular Biology of Bacterial-Host Cell Interactions 1993"},{"key":"e_1_3_1_35_2","first-page":"249","article-title":"Case records of the Massachusetts General Hospital.","volume":"332","author":"Fishman J. A.","year":"1995","unstructured":"Fishman J. A. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 332 1995 249 258","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1543"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0272989X9601600110","article-title":"Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.","volume":"16","author":"Freedberg K.","year":"1996","unstructured":"Freedberg K. Hardy W. Holzman R. Tosteson A. Craven D. Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients. Med. Decision Making 16 1996 29 35","journal-title":"Med. Decision Making"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2534"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.47.2.544-548.1985"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.107.4.1018","article-title":"The impact of prophylaxis on outcome and resource.","volume":"107","author":"Gallant J. E.","year":"1995","unstructured":"Gallant J. E. McAvinue S. M. Moore R. D. Bartlett J. G. Stanton D. Chaisson R. E. The impact of prophylaxis on outcome and resource. Chest 107 1995 1018 1023","journal-title":"Chest"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113503"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s004360050075","article-title":"Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization.","volume":"82","author":"Gigliotti F.","year":"1996","unstructured":"Gigliotti F. McCool T. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol. Res. 82 1996 90 91","journal-title":"Parasitol. Res."},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"Dapson-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection.","volume":"328","author":"Girard P.","year":"1993","unstructured":"Girard P. Landman R. Gaudebout C. Olivares R. Saimot A. G. Jelazko P. Certain A. Boue F. Bouvet E. Lecompte T. Coulaud J. The PRIO Study Group Dapson-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N. Engl. J. Med. 328 1993 1514 1520","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/infdis\/149.2.143","article-title":"Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporine and steroids.","volume":"149","author":"Hardy A. M.","year":"1984","unstructured":"Hardy A. M. Wajszczuk C. P. Suffredini A. F. Hakala T. R. Ho M. Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporine and steroids. J. Infect. Dis. 149 1984 143 147","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212243272604"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0360-3016(94)00541-R","article-title":"Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.","volume":"32","author":"Hartsell W. F.","year":"1995","unstructured":"Hartsell W. F. Czyzewski E. A. Ghalie R. Kaizer H. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Inter. J. Radiat. Oncol. Biol. Physics 32 1995 69 73","journal-title":"Inter. J. Radiat. Oncol. Biol. Physics"},{"key":"e_1_3_1_47_2","first-page":"250","article-title":"Multiple pulmonary infections in a patient with acquired immunodeficiency syndrome.","volume":"2","author":"Hennequin C.","year":"1993","unstructured":"Hennequin C. Dupouy-Camet J. Giraud T. Bougnoux M. E. Dhainaut J. F. Tourte-Schaefer C. Multiple pulmonary infections in a patient with acquired immunodeficiency syndrome. Eur. J. Med. 2 1993 250 251","journal-title":"Eur. J. Med."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02111870","article-title":"Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.","volume":"14","author":"Hennequin C.","year":"1995","unstructured":"Hennequin C. Page B. Roux P. Legendre C. Kreis H. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur. J. Clin. Microbiol. Infect. Dis. 14 1995 122 126","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00007890-198903000-00032","article-title":"The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation.","volume":"47","author":"Higgins R. M.","year":"1989","unstructured":"Higgins R. M. Bloom S. L. Hopkin J. M. Morris P. J. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 47 1989 558 560","journal-title":"Transplantation"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM199104183241602","article-title":"A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.","volume":"324","author":"Hirschel B.","year":"1991","unstructured":"Hirschel B. Lazzarin A. Chopard P. Opravil M. Furrer H. Ruttimann S. Vernazza P. Chave J. Ancarani F. Gabriel V. Heald A. King R. Malinverni R. Martin J. Mermillod B. Nicod L. Simoni L. Vivrito M. C. Zerboni R. Swiss Group for Clinical Studies on AIDS A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N. Engl. J. Med. 324 1991 1079 1083","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/ajrccm\/144.4.756","article-title":"Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men.","volume":"144","author":"Hoover D. R.","year":"1991","unstructured":"Hoover D. R. Graham N. M. H. Bacellar H. Schrager L. K. Kaslow R. Visscher B. Murphy R. Anderson R. Saah A. Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. Am. Rev. Respir. Dis. 144 1991 756 759","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJM199312233292604","article-title":"Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis.","volume":"329","author":"Hoover D. R.","year":"1993","unstructured":"Hoover D. R. Saah A. J. Bacellar H. Phair J. Detels R. Anderson R. Kaslow R. A. Multicenter AIDS Cohort Study Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N. Engl. J. Med. 329 1993 1922 1926","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(83)90287-8","article-title":"Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid.","author":"Hopkin J. M.","year":"1983","unstructured":"Hopkin J. M. Turney J. H. Young J. A. Adu D. Michael J. Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet ii 1983 299 301","journal-title":"Lancet"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","article-title":"Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.","volume":"171","author":"Hughes W.","year":"1995","unstructured":"Hughes W. LaFon S. Scott J. Masur H. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Infect. Dis. 171 1995 1295 1301","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360912","article-title":"Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis.","volume":"36","author":"Hughes W. T.","year":"1975","unstructured":"Hughes W. T. Feldman S. Aur R. J. Verzosa M. S. Hustu H. O. Simone J. V. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36 1975 2004 2009","journal-title":"Cancer"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","unstructured":"Hughes W. T. Pneumocystis carinii pneumonitis. 1987 CRC Press Inc. Boca Raton Fla","DOI":"10.1056\/NEJM198710153171608"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) and trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.","volume":"328","author":"Hughes W. T.","year":"1993","unstructured":"Hughes W. T. Leoung G. Kramer F. Bozzette S. A. Safrin S. Frame P. Clumeck N. Masur H. Lancaster D. Chan C. Lavelle J. Rosenstock J. Falloon J. Feinberg J. LaFon S. Rogers M. Sattler F. Comparison of atovaquone (566C80) and trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328 1993 1521 1527","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80028-6"},{"key":"e_1_3_1_59_2","first-page":"47S","article-title":"Treatment of Pneumocystis carinii pneumonitis with trimethoprim\/sulfamethoxazole.","volume":"112","author":"Hughes W. T.","year":"1975","unstructured":"Hughes W. T. Feldman S. Sanyal S. K. Treatment of Pneumocystis carinii pneumonitis with trimethoprim\/sulfamethoxazole. Can. Med. Assoc. J. 112 1975 47S 50S","journal-title":"Can. Med. Assoc. J."},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.5.3.289"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706253162604"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.300"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.436"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii pneumonia prophylactic regimens.","volume":"156","author":"Ioannidis J. P.","year":"1996","unstructured":"Ioannidis J. P. Cappelleri J. C. Skolnik P. R. Lau J. Sacks H. S. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii pneumonia prophylactic regimens. Arch. Intern. Med. 156 1996 177 188","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.325"},{"key":"e_1_3_1_66_2","first-page":"758","article-title":"Pneumocystis carinii pneumonia in infants after heart transplantation.","volume":"15","author":"Janner D.","year":"1996","unstructured":"Janner D. Bork J. Baum M. Chinnock R. Pneumocystis carinii pneumonia in infants after heart transplantation. J. Heart Lung Transplant. 15 1996 758 763","journal-title":"J. Heart Lung Transplant."},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(93)90072-Z","article-title":"The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells.","volume":"80","author":"Jones H. E.","year":"1993","unstructured":"Jones H. E. Blundell G. K. Tidwell R. R. Hall J. E. Farr S. J. Richards R. J. The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells. Toxicology 80 1993 1 12","journal-title":"Toxicology"},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-199303000-00008","article-title":"Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals.","volume":"7","author":"Jorde U. P.","year":"1993","unstructured":"Jorde U. P. Horowitz H. W. Wormser G. P. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS 7 1993 355 359","journal-title":"AIDS"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.2.644-650.1994"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00007611-199004000-00010","article-title":"Clindamycin\/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumoniain patients with AIDS.","volume":"83","author":"Kay R.","year":"1990","unstructured":"Kay R. DuBois R. E. Clindamycin\/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumoniain patients with AIDS. South. Med. J. 83 1990 403 404","journal-title":"South. Med. J."},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinids\/14.5.1005","article-title":"Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.","volume":"14","author":"Kovacs J.","year":"1992","unstructured":"Kovacs J. Masur H. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 14 1992 1005 1009","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-5-663"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53422-0"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000166667","article-title":"Pneumocystis carinii pneumonia in renal transplant recipients.","volume":"2","author":"Kuller J.","year":"1982","unstructured":"Kuller J. First M. R. D\u2019Archiardi R. Munda R. Pneumocystis carinii pneumonia in renal transplant recipients. Am. J. Nephrol. 2 1982 312 315","journal-title":"Am. J. Nephrol."},{"key":"e_1_3_1_75_2","unstructured":"Lake K. Drug interactions in transplant patients Handbook of cardiac transplantation. 1995 173 200 Handley & Belfus Philadelphia Pa"},{"key":"e_1_3_1_76_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/175.2.482","article-title":"Dihydropteroate synthase polymorphisms in Pneumocystis.","volume":"175","author":"Lane B. R.","year":"1997","unstructured":"Lane B. R. Ast J. C. Hossler P. A. Mindell D. P. Bartlett M. S. Smith J. W. Meshnick S. R. Dihydropteroate synthase polymorphisms in Pneumocystis. J. Infect. Dis. 175 1997 482 485","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.7.1687-1690.1997"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197609232951308"},{"key":"e_1_3_1_79_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/ajrccm\/144.4.760","article-title":"Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus.","volume":"144","author":"Levine S. J.","year":"1991","unstructured":"Levine S. J. Masur H. Gill V. J. Feuerstein I. Suffredini A. F. Brown D. Lane H. C. Yarchoan R. Shelhamer J. H. Ognibene F. P. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am. Rev. Respir. Dis. 144 1991 760 764","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.12.2904-2912.1994"},{"key":"e_1_3_1_81_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00007890-199608150-00022","article-title":"Incidence of Pneumocystis carinii pneumonia after renal transplantation.","volume":"63","author":"Lufft V.","year":"1996","unstructured":"Lufft V. Kliem V. Behrend M. Pichlmayr R. Koch K. M. Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Transplantation 63 1996 421 423","journal-title":"Transplantation"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-3-223"},{"key":"e_1_3_1_83_2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0968-0896(97)00065-5","article-title":"Discovery of selective, small molecule inhibitors of RNA complexes. II. Self-splicing group I intron ribozyme.","volume":"5","author":"Mei H. Y.","year":"1997","unstructured":"Mei H. Y. Cui M. Lemrow S. M. Czarnik A. W. Discovery of selective, small molecule inhibitors of RNA complexes. II. Self-splicing group I intron ribozyme. Bioorg. Med. Chem. 5 1997 1185 1195","journal-title":"Bioorg. Med. Chem."},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/136.1.43"},{"key":"e_1_3_1_85_2","doi-asserted-by":"crossref","unstructured":"Miller R. F. J. Le Noury E. L. Corbett J. M. Felton and K. M. De Cock. 1987. Pneumocystis carinii infection: current treatment and prevention. J. Antimicrob. Chemother. 37 (Suppl. B) : 35\u201353.","DOI":"10.1093\/jac\/37.suppl_B.33"},{"key":"e_1_3_1_86_2","first-page":"101A","article-title":"Dapsone is ineffective therapy for Pneumocystis pneumonia in patients with AIDS.","volume":"34","author":"Mills J.","year":"1986","unstructured":"Mills J. Leoung G. Medina I. Hughes W. Hopewll P. Wofsy C. Dapsone is ineffective therapy for Pneumocystis pneumonia in patients with AIDS. Clin. Res. 34 1986 101A","journal-title":"Clin. Res."},{"key":"e_1_3_1_87_2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/infdis\/167.6.1470","article-title":"An improved method for the long term maintenance of Pneumocystis carinii in vitro.","volume":"167","author":"Mirovsky P.","year":"1993","unstructured":"Mirovsky P. Fishman J. A. An improved method for the long term maintenance of Pneumocystis carinii in vitro. J. Infect. Dis. 167 1993 1470 1473","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_88_2","first-page":"303","article-title":"The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.","volume":"156","author":"Mohle-Boetani J.","year":"1992","unstructured":"Mohle-Boetani J. Akula S. Holodniy M. Katzenstein D. Garcia G. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West. J. Med. 156 1992 303 306","journal-title":"West. J. Med."},{"key":"e_1_3_1_89_2","first-page":"1068","article-title":"Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immunodeficiency syndrome.","volume":"151","author":"Montgomery A. B.","year":"1995","unstructured":"Montgomery A. B. Feigal D. W. Sattler F. Mason G. R. Catanzano A. Edison R. Markowitz N. Johnson E. Ozowa S. Rouzar M. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immunodeficiency syndrome. Am. J. Respir. Crit. Care 151 1995 1068 1074","journal-title":"Am. J. Respir. Crit. Care"},{"key":"e_1_3_1_90_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7164\/antibiotics.47.755","article-title":"Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii.","volume":"47","author":"Morris S. A.","year":"1994","unstructured":"Morris S. A. Schwartz R. E. Sesin D. F. Masurekar P. Hallada T. C. Schmatz D. M. Bartial K. Hensens O. D. Zink D. L. Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii. J. Antibiot. 47 1994 755 764","journal-title":"J. Antibiot."},{"key":"e_1_3_1_91_2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/ajrccm.152.4.7551387","article-title":"Community-acquired pneumonia: impact of immune status.","volume":"152","author":"Mundy L. M.","year":"1995","unstructured":"Mundy L. M. Auwaerter P. G. Oldach D. Warner M. L. Burton A. Vance E. Gaydos C. A. Joseph J. M. Gopalan R. Moore R. D. Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med. 152 1995 1309 1315","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_92_2","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.135.4.2374","article-title":"Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.","volume":"135","author":"Murray H. W.","year":"1985","unstructured":"Murray H. W. Gellene R. A. Libby D. M. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J. Immunol. 135 1985 2374 2377","journal-title":"J. Immunol."},{"key":"e_1_3_1_93_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1378\/chest.105.2.417","article-title":"Utility of inhaled pentamidine prophylaxis in lung transplant reciepients.","volume":"105","author":"Nathan S. D.","year":"1994","unstructured":"Nathan S. D. Ross D. J. Zakowski P. Kass R. M. Koerner S. K. Utility of inhaled pentamidine prophylaxis in lung transplant reciepients. Chest 105 1994 417 420","journal-title":"Chest"},{"issue":"5","key":"e_1_3_1_94_2","first-page":"S41","article-title":"Infectious complications of lung and heart-lung transplantation.","volume":"13","author":"Nicod L. P.","year":"1996","unstructured":"Nicod L. P. Infectious complications of lung and heart-lung transplantation. Rev. Mal. Respir. 13 5 Suppl. 1996 S41 S47","journal-title":"Rev. Mal. Respir."},{"key":"e_1_3_1_95_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/168.1.84","article-title":"Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection.","volume":"168","author":"Nottet H. S. L. M.","year":"1993","unstructured":"Nottet H. S. L. M. de Graaf L. de Vos N. M. Bakker L. J. van Strijp J. A. G. Visser M. R. Verhoef J. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168 1993 84 91","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_96_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007890-199308000-00021","article-title":"Prevention of Pneumocystis carinii in cardiac transplantation recipients by trimethoprim-sulfamethoxazole.","volume":"56","author":"Olsen S. L.","year":"1993","unstructured":"Olsen S. L. Renlund D. G. O\u2019Connell J. B. Taylor D. O. Lassetter J. E. Eastburn J. Prevention of Pneumocystis carinii in cardiac transplantation recipients by trimethoprim-sulfamethoxazole. Transplantation 56 1993 359 362","journal-title":"Transplantation"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1197"},{"key":"e_1_3_1_98_2","unstructured":"Opravil M. Joos B. Luthy R. Dapsone-pyrimethamine vs. aerosolized pentamidine for combined prophylaxis of PCP and toxoplasmic encephalitis abstr. PO-B10-1429. Abstracts of the IX International Conference on AIDS 1993"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.5.1056"},{"key":"e_1_3_1_100_2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/513988","article-title":"Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus.","volume":"175","author":"Oz H. S.","year":"1997","unstructured":"Oz H. S. Hughes W. T. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus. J. Infect. Dis. 175 1997 901 904","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_101_2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.1970.03180060052010","article-title":"Pneumocystis carinii pneumonia in a hospital for children: epidemiologic aspects.","volume":"214","author":"Perera D. R.","year":"1970","unstructured":"Perera D. R. Western K. A. Johnson H. D. Johnson W. W. Schultz M. G. Akers P. V. Pneumocystis carinii pneumonia in a hospital for children: epidemiologic aspects. JAMA 214 1970 1074 1078","journal-title":"JAMA"},{"key":"e_1_3_1_102_2","doi-asserted-by":"crossref","unstructured":"Phair J. H. Masur P. Gross K. Holmes and J. Kaplan. 1995. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus. Clin. Infect. Dis. 21 (Suppl. 1) : S128\u2013S129.","DOI":"10.1093\/clinids\/21.Supplement_1.S128"},{"key":"e_1_3_1_103_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1203\/00006450-197704000-00010","article-title":"Propagation of Pneumocystis carinii in vitro.","volume":"11","author":"Pifer L. L.","year":"1977","unstructured":"Pifer L. L. Hughes W. T. Murphy M. J. Propagation of Pneumocystis carinii in vitro. Pediatr. Res. 11 1977 305 316","journal-title":"Pediatr. Res."},{"key":"e_1_3_1_104_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000246109","article-title":"Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi\u2019s sarcoma.","volume":"194","author":"Plettenberg A.","year":"1997","unstructured":"Plettenberg A. van Dyk U. Stoehr A. Albrecht H. Stellbrink H. J. Berger J. Meigel W. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi\u2019s sarcoma. Dermatology 194 1997 234 237","journal-title":"Dermatology"},{"key":"e_1_3_1_105_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199304000-00008","article-title":"Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.","volume":"7","author":"Podzamczer D.","year":"1993","unstructured":"Podzamczer D. Santin M. Jimenez J. Casanova A. Bolao F. Gudiol G. R. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS 7 1993 501 506","journal-title":"AIDS"},{"key":"e_1_3_1_106_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-122-10-199505150-00004","article-title":"Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.","volume":"122","author":"Podzamczer D.","year":"1995","unstructured":"Podzamczer D. Salazar A. Jiminez J. Consiglio E. Santrin M. Casanova A. Rufi G. Gudiol F. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann. Intern. Med. 122 1995 755 761","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_107_2","first-page":"273","article-title":"Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine and pyrimethamine combination.","volume":"13","author":"Post C.","year":"1971","unstructured":"Post C. Fakoughi T. Dutz W. Bandarizadeh B. Kohout E. E. Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine and pyrimethamine combination. Curr. Ther. Res. 13 1971 273 279","journal-title":"Curr. Ther. Res."},{"key":"e_1_3_1_108_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00042560-199606010-00009","article-title":"Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic HIV infection.","volume":"12","author":"Principi N.","year":"1996","unstructured":"Principi N. Marchisio P. Onorato J. Gabiano C. Galli L. Caselli D. Morandi B. Campelli A. Clerici M. Gattinora G. C. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic HIV infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12 1996 158 163","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"e_1_3_1_109_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0163-4453(96)91312-2","article-title":"Risks and benefits of aerosolized pentamidine and cotrimoxazolee in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.","volume":"32","author":"Rizzardi G.","year":"1996","unstructured":"Rizzardi G. Lazzarin A. Musicco M. Frigerio D. Maillard M. Lucchini M. Moroni M. Risks and benefits of aerosolized pentamidine and cotrimoxazolee in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group. J. Infect. 32 1996 123 131","journal-title":"J. Infect."},{"key":"e_1_3_1_110_2","first-page":"99","article-title":"Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.","volume":"31","author":"Rizzardi G. P.","year":"1995","unstructured":"Rizzardi G. P. Lazzarin A. Musicco M. Frigerio D. Maillard M. Lucchini M. Moroni M. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. J. Infect. Dis. 31 1995 99 105","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_111_2","unstructured":"Robbins J. B. DeVita V. T. Dutz W. Symposium on Pneumocystis carinii infection. NCI Monograph No. 43. 1976 National Cancer Institute Washington D.C"},{"key":"e_1_3_1_112_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archderm.1994.01690110049005","article-title":"Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.","volume":"130","author":"Roudier C.","year":"1994","unstructured":"Roudier C. Caumes E. Rogeaux O. Bricaire F. Gentilini M. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Arch. Dermatol. 130 1994 1383 1386","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_113_2","first-page":"143","article-title":"An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia.","volume":"132","author":"Ruebush T. K.","year":"1978","unstructured":"Ruebush T. K. Weinstein R. A. Baehner R. L. Wolff D. Bartlett M. S. Gonzales-Crussi F. Sulzer A. J. Schultz M. G. An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. J. Dis. Child. 132 1978 143 148","journal-title":"J. Dis. Child."},{"key":"e_1_3_1_114_2","first-page":"31","article-title":"Pneumocystis carinii pneumonia in patients with solid organ transplants: a report of 5 cases.","volume":"197","author":"Ruiz Ruiz J.","year":"1997","unstructured":"Ruiz Ruiz J. Yebra Bango M. Fernandez Fernandez J. Alonso Pulpon L. Pneumocystis carinii pneumonia in patients with solid organ transplants: a report of 5 cases. Rev. Clin. Esp. 197 1997 31 34","journal-title":"Rev. Clin. Esp."},{"key":"e_1_3_1_115_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0140-6736(91)93402-U","article-title":"Low dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.","volume":"337","author":"Ruskin J.","year":"1991","unstructured":"Ruskin J. LaRiviere M. Low dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 337 1991 468 471","journal-title":"Lancet"},{"key":"e_1_3_1_116_2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.1995.03520390057033","article-title":"Predictors of failure of Pneumocystis carinii pneumonia prophylaxis.","volume":"273","author":"Saah A.","year":"1995","unstructured":"Saah A. Hoover D. R. Peng Y. Phair J. P. Visscher B. Kingsley L. A. Schrager L. K. Predictors of failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 273 1995 1197 1202","journal-title":"JAMA"},{"key":"e_1_3_1_117_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/170.4.912","article-title":"Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death.","volume":"170","author":"Safrin S.","year":"1994","unstructured":"Safrin S. Lee B. Sande M. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170 1994 912 917","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_118_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/172.3.656","article-title":"Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia.","volume":"172","author":"Salmon Ceron D.","year":"1995","unstructured":"Salmon Ceron D. Fontbonne A. Saba J. May T. Raffi F. Chidiac C. Patey G. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J. Infect. Dis. 172 1995 656 664","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_119_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinids\/7.5.625","article-title":"Pentamidine: a review.","volume":"7","author":"Sands F.","year":"1985","unstructured":"Sands F. Kron M. Brown R. Pentamidine: a review. Rev. Infect. Dis. 7 1985 625 634","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_1_120_2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1378\/chest.109.5.1250","article-title":"Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients.","volume":"109","author":"Saukkonen K.","year":"1996","unstructured":"Saukkonen K. Garland R. Koziel H. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Chest 109 1996 1250 1255","journal-title":"Chest"},{"key":"e_1_3_1_121_2","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.","volume":"327","author":"Schneider M.","year":"1992","unstructured":"Schneider M. Margriet M. E. Hoepelman A. Karrel J. Eeftinck-Schattenkerk J. Nielsen T. L. van der Graaf Y. Frissen J. van der Ende I. M. E. Kolsters A. F. P. Borleffs J. C. C. the Dutch AIDS Treatment Group A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327 1992 1836 1841","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_122_2","first-page":"479","article-title":"Pulmonary nocardiosis in a patient with a bone marrow transplant.","volume":"15","author":"Shearer C.","year":"1995","unstructured":"Shearer C. Chandrasekar P. H. Pulmonary nocardiosis in a patient with a bone marrow transplant. Bone Marrow Transplant. 15 1995 479 481","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_1_123_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/169.1.18","article-title":"Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status.","volume":"169","author":"Sierra-Madero J. G.","year":"1994","unstructured":"Sierra-Madero J. G. Toossi Z. Hom D. L. Finegan C. K. Hoenig E. Rich E. A. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169 1994 18 27","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_124_2","doi-asserted-by":"crossref","unstructured":"Simonds R. W. Hughes J. Feinberg and T. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21 (Suppl. 1) : S44\u2013S48.","DOI":"10.1093\/clinids\/21.Supplement_1.S44"},{"key":"e_1_3_1_125_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJM199503233321206","article-title":"Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States.","volume":"332","author":"Simonds R. J.","year":"1995","unstructured":"Simonds R. J. Lindegren M. L. Thomas P. Hanson D. Caldwell B. Scott G. Rogers M. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N. Engl. J. Med. 332 1995 786 790","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_126_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042560-199608150-00006","article-title":"Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals.","volume":"15","author":"Sin D.","year":"1996","unstructured":"Sin D. Shafran S. Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15 1996 477 481","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"e_1_3_1_127_2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007890-199602150-00013","article-title":"Pulmonary infections in liver transplant recipients receiving tacrolimus.","volume":"61","author":"Singh N.","year":"1996","unstructured":"Singh N. Gayowski T. Wagener M. Marino I. R. Yu V. L. Pulmonary infections in liver transplant recipients receiving tacrolimus. Transplantation 61 1996 396 401","journal-title":"Transplantation"},{"key":"e_1_3_1_128_2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00002030-199210000-00017","article-title":"Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and hematological toxicity.","volume":"6","author":"Slavin M.","year":"1992","unstructured":"Slavin M. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and hematological toxicity. AIDS 6 1992 1169 1174","journal-title":"AIDS"},{"key":"e_1_3_1_129_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9343(93)90187-T","article-title":"Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors.","volume":"94","author":"Slivka A.","year":"1993","unstructured":"Slivka A. Wen P. Y. Shea W. M. Loeffler J. S. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am. J. Med. 94 1993 216 219","journal-title":"Am. J. Med."},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.489"},{"key":"e_1_3_1_131_2","unstructured":"Swartzberg J. E. Remington J. S. Transplant associated infections Hospital infections. Bennett J. V. Brachman P. S. 1979 453 488 Little Brown & Co. Boston Mass"},{"key":"e_1_3_1_132_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.97.1.59","article-title":"Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants.","volume":"97","author":"Thea D. M.","year":"1996","unstructured":"Thea D. M. Lambert G. Weedon J. Matheson P. B. Abrams E. J. Bamji M. Straus T. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. Pediatrics 97 1996 59 64","journal-title":"Pediatrics"},{"key":"e_1_3_1_133_2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/00007890-199611270-00026","article-title":"Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation\u2014an open clinical trial.","volume":"62","author":"Torre Cisneros J.","year":"1996","unstructured":"Torre Cisneros J. de la Mata M. Lopez Cillero P. Sanchez Guijo P. Mino P. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation\u2014an open clinical trial. Transplantation 62 1996 1519 1521","journal-title":"Transplantation"},{"key":"e_1_3_1_134_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01744375","article-title":"Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation.","volume":"71","author":"van Dissel J. T.","year":"1995","unstructured":"van Dissel J. T. Zijlmans J. M. Kroes A. C. Fibbe W. E. Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation. Ann. Hematol. 71 1995 253 255","journal-title":"Ann. Hematol."},{"key":"e_1_3_1_135_2","first-page":"120","article-title":"Parasitare penumonie: \u201cinterstitielle\u201d plasmazell pneumonie der frugeburten verursach durch Pneumocystis carinii.","volume":"158","author":"Vanek J.","year":"1952","unstructured":"Vanek J. Jirovec O. Parasitare penumonie: \u201cinterstitielle\u201d plasmazell pneumonie der frugeburten verursach durch Pneumocystis carinii. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 158 1952 120 127","journal-title":"Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig."},{"key":"e_1_3_1_136_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/169.2.456","article-title":"Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).","volume":"169","author":"Voeller D.","year":"1994","unstructured":"Voeller D. Kovacs J. Andrawis V. Chu E. Masur H. Allegra C. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone). J. Infect. Dis. 169 1994 456 459","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_137_2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/infdis\/168.4.836","article-title":"Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques.","volume":"168","author":"Vogel P.","year":"1993","unstructured":"Vogel P. Miller C. J. Lowenstine L. L. Lackner A. A. Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J. Infect. Dis. 168 1993 836 843","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_138_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.4.979"},{"key":"e_1_3_1_139_2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/00002030-199311000-00018","article-title":"Changing incidence of Pneumocystis carinii pneumonia as the initial AIDS-defining disease in the United Kingdom.","volume":"7","author":"Wall P. G.","year":"1993","unstructured":"Wall P. G. Porter K. Noone A. Goldberg D. J. Changing incidence of Pneumocystis carinii pneumonia as the initial AIDS-defining disease in the United Kingdom. AIDS 7 1993 1523 1525","journal-title":"AIDS"},{"key":"e_1_3_1_140_2","unstructured":"Walzer P. D. Pneumocystis carinii pneumonia. 1994 Marcel Dekker Inc. New York N.Y"},{"key":"e_1_3_1_141_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-80-1-83","article-title":"Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features.","volume":"80","author":"Walzer P. D.","year":"1974","unstructured":"Walzer P. D. Perl D. P. Krogstad D. J. Rawson P. G. Schultz M. G. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. Ann. Intern. Med. 80 1974 83 93","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_142_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0166-6851(89)90067-4","article-title":"Phylogenetic association of Pneumocystis carinii with the \u2019rhizopoda\/myxomycota\/zygomycota group\u2019 indicated by comparison of 5S ribosomal RNA sequences.","volume":"32","author":"Watanabe J.","year":"1989","unstructured":"Watanabe J. Hori H. Tanabe K. Nakamura Y. Phylogenetic association of Pneumocystis carinii with the \u2019rhizopoda\/myxomycota\/zygomycota group\u2019 indicated by comparison of 5S ribosomal RNA sequences. Mol. Biochem. Parasitol. 32 1989 163 168","journal-title":"Mol. Biochem. Parasitol."},{"key":"e_1_3_1_143_2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-92-6-762","article-title":"Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia.","volume":"92","author":"Winston D. J.","year":"1980","unstructured":"Winston D. J. Lau W. K. Gale R. P. Young L. S. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann. Intern. Med. 92 1980 762 769","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_144_2","unstructured":"Young R. C. DeVita V. T. Treatment of Pneumocystis carinii pneumonia Symposium on Pneumocystis carinii infection. NCI Monograph No. 43. Robbins J. B. DeVita V. T. Dutz W. 1976 193 198 National Cancer Institute Washington D.C"},{"key":"e_1_3_1_145_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.4140-4145.1992"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.5.995","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.5.995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:46:28Z","timestamp":1693943188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.42.5.995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1128\/AAC.42.5.995"],"URL":"https:\/\/doi.org\/10.1128\/aac.42.5.995","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"1998-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}